Hotline Archive

Below are links to hotlines published prior to 1999.

• Etanercept (Enbrel) Label Updated Following Post-marketing Infectious Events 07/99
• Rofecoxib (Vioxx) 07/99
• Zinaxin (Ginger Root) 05/99
• FDA Approval of Prosorba Immmunoadsorption Column 05/99
• Update on New Agents for Rheumatoid Arthritis: Celebrex, Enbrel, Arava 03/99
• Preliminary FDA Approval of Etanercept (Enbrel) 09/98
• Preliminary FDA Approval of Leflunomide (Arava) 08/98
• Minocycline Treatment for Scleroderma 05/98
• Hyaluronic Acid Treatment for Osteoarthritis 07/97
• Glucosamine Sulfate and Chondroitin Sulfate for Osteoarthritis 01/97
• Treatment of RA with Methotrexate Alone, Sulfasalazine and Hydroxychloroquine, or a Combination of All Three Medications 05/96
• Treatment of RA by Immunization with White Blood Cells 02/96
• Alendronate (Fosamax) Trials in Osteoporosis 10/95
• Cyclosporine and Methotrexate in Rheumatoid Arthritis 07/95
• Lymphoproliferative Disease in Patients with Autoimmune Disease on Low-Dose Methotrexate 06/95
• Minocycline as Treatment in Rheumatoid Arthritis 01/95
• Risk of Renal Failure With Angelesic Use 12/94
• Is There a Link Between Arthritis and Cardiovascular Disease? 11/94
• Cartilage Growth Factor (TGF-ß) In Osteoarthritis 03/94
• Why the Bones Break 02/94